stockrowGRAIL, Inc. (GRAL) vs Sotera Health Company (SHC)
- GRAIL, Inc. GRAL 119.24 +0.09%
- Sotera Health Company SHC 15.77 −0.63%
GRAIL, Inc. and Sotera Health Company are both Diagnostics & Research companies. GRAIL, Inc. is the larger, with a market value of $5.3B against $4.5B — 1.2× the size. GRAIL, Inc. has negative trailing earnings, so its P/E is not meaningful; Sotera Health Company trades at 26.3×. GRAIL, Inc. grew revenue faster over the last twelve months: 17.5% against 6.90%. Sotera Health Company has the higher net margin (14.1% vs −243.8%) and the higher return on invested capital (9.80% vs −14.7%). Across the 17 metrics below, Sotera Health Company leads on 11 and GRAIL, Inc. on 6.
Valuation
Profitability
| Metric | GRAL | SHC | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 0.00% | 54.62% | 48.32% |
| Operating margin | (347.28%) | 32.66% | (5.68%) |
| Net margin | (243.80%) | 14.11% | (4.10%) |
| Free cash flow margin | (187.27%) | 11.01% | 0.00% |
| Return on equity | (17.31%) | 27.03% | 0.00% |
| Return on assets | (15.24%) | 5.28% | (6.05%) |
| Return on invested capital | (14.74%) | 9.80% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack